Oncology

BioNTech’s ASCO 2025 oncology advances: New data on bispecif...
At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate cancer, and melanoma.
Oncology

Breaking barriers to CAR T-cell therapy: The vision for expa...
Live from ASCO 2025: Prof. Dr Jason Westin discusses CAR-T Vision, patient access, and the push to expand therapy reach in rare blood cancers.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
Newsletters and Deep Dive
digital magazine